Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)

<b>Background/Objectives</b>: This study analyzed demographic, clinical, laboratory, and outcome data from patients hospitalized with Coronavirus disease 2019 in eastern Poland between March 2020 and December 2024. This study aimed to assess sex-related differences in clinical features, treatments, and outcomes, and to identify predictors of mortality and mechanical ventilation in hospitalized patients. <b>Methods</b>: A retrospective cohort of 2811 adults hospitalized across four infectious disease centers was examined. Data included demographics, comorbidities, symptoms, laboratory findings, treatments, and clinical outcomes. Multivariable logistic regression was performed to identify predictors of mortality and mechanical ventilation. <b>Results</b>: The cohort comprised 1398 females and 1413 males. Women were older (median 67.5 vs. 63 years, <i>p</i> < 0.0001) and had a higher burden of comorbidities, while men presented with more severe baseline respiratory status and higher inflammatory markers. Oxygen therapy was required more frequently in men (60% vs. 49.9%, <i>p</i> < 0.0001). Overall mortality was 8.9% and did not differ significantly by sex, although men aged 60-79 years had higher mortality than women (11.2% vs. 7.7%, <i>p</i> = 0.0422). Independent predictors of mortality (OR, 95%CI) included age ≥ 80 years (3.78, 2.66-5.39), procalcitonin > 1 ng/mL (OR 4.07, 2.54-6.52), interleukin-6 (IL-6) > 100 pg/mL (OR 2.24, 1.53-3.27), and oxygen therapy at admission (OR 9.41, 5.22-16.97). Predictors of mechanical ventilation were age ≥ 80 years (7.14, 1.75-33.33), procalcitonin > 1 ng/mL (OR 2.09, 1.2-3.63), IL-6 > 100 pg/mL (OR 2.3, 1.4-3.78), and CRP at admission (OR 1.82, 1.15-2.88). <b>Conclusions</b>: Sex-related disparities in clinical presentation, laboratory profiles, and treatment strategies were evident, but mortality differences were driven primarily by age and inflammatory burden rather than sex alone. Elevated procalcitonin, high IL-6, and early oxygen requirement emerged as robust predictors of poor outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-02-03
DOI
https://doi.org/10.3390/jcm15031207
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)

Krystyna Dobrowolska, Michał Brzdęk, Marcin Hawro, Piotr Czupryna et al.
Journal of Clinical Medicine
COVID-19 Clinical Research Studies
article

Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)

Krystyna Dobrowolska, Michał Brzdęk, Marcin Hawro, Piotr Czupryna, Krzysztof Tomasiewicz, Łukasz Supronowicz, Małgorzata Wajdowicz, Piotr Rzymski, Magdalena Rogalska, Jakub Janczura, Kinga Brzdęk
article en

Abstract

<b>Background/Objectives</b>: This study analyzed demographic, clinical, laboratory, and outcome data from patients hospitalized with Coronavirus disease 2019 in eastern Poland between March 2020 and December 2024. This study aimed to assess sex-related differences in clinical features, treatments, and outcomes, and to identify predictors of mortality and mechanical ventilation in hospitalized patients. <b>Methods</b>: A retrospective cohort of 2811 adults hospitalized across four infectious disease centers was examined. Data included demographics, comorbidities, symptoms, laboratory findings, treatments, and clinical outcomes. Multivariable logistic regression was performed to identify predictors of mortality and mechanical ventilation. <b>Results</b>: The cohort comprised 1398 females and 1413 males. Women were older (median 67.5 vs. 63 years, <i>p</i> < 0.0001) and had a higher burden of comorbidities, while men presented with more severe baseline respiratory status and higher inflammatory markers. Oxygen therapy was required more frequently in men (60% vs. 49.9%, <i>p</i> < 0.0001). Overall mortality was 8.9% and did not differ significantly by sex, although men aged 60-79 years had higher mortality than women (11.2% vs. 7.7%, <i>p</i> = 0.0422). Independent predictors of mortality (OR, 95%CI) included age ≥ 80 years (3.78, 2.66-5.39), procalcitonin > 1 ng/mL (OR 4.07, 2.54-6.52), interleukin-6 (IL-6) > 100 pg/mL (OR 2.24, 1.53-3.27), and oxygen therapy at admission (OR 9.41, 5.22-16.97). Predictors of mechanical ventilation were age ≥ 80 years (7.14, 1.75-33.33), procalcitonin > 1 ng/mL (OR 2.09, 1.2-3.63), IL-6 > 100 pg/mL (OR 2.3, 1.4-3.78), and CRP at admission (OR 1.82, 1.15-2.88). <b>Conclusions</b>: Sex-related disparities in clinical presentation, laboratory profiles, and treatment strategies were evident, but mortality differences were driven primarily by age and inflammatory burden rather than sex alone. Elevated procalcitonin, high IL-6, and early oxygen requirement emerged as robust predictors of poor outcomes.

Journal of Clinical MedicineVol. 15(3)
Poznan University of Medical Sciences (PL), Medical University of Lublin (PL), Medical University of Białystok (PL), Jan Kochanowski University (PL), Copernicus Memorial Hospital (PL), Medical University of Lodz (PL), University of Rzeszów (PL)
Good health and well-being
Openalex Percentile: Top 66%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.